Citation

GD McSherry, David E. Shapiro, Ph.D., RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999 Jun 01; 134(6):717-24.

Citation

Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999 Jan 01; 66(1):16-24.

Citation

I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Rae Cooper, M.P.H., M.D., Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro. Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Apr 15; 20(5):463-467.

Citation

Mary Culnane, C.R.N.P., M.S., Bethann Cunningham-Schrader, B.A., M.S., James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Sophia S. Lee, M.S., George D. McSherry, M.D., Michael T. Brady, M.D., Karen J. O'Donnell, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Steven Gortmaker, Ph.D., David E. Shapiro, Ph.D. Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women. The Journal of the American Medical Association. 1999 Jan 13; 281(2):151-57.

Citation

Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Florence H. Yong, Terence Fenton, Richard C. Brundage, Douglas Manion, Nancy M. Ruiz, Merril Gersten, Mark Becker, James McNamara, Lynne M. Mofenson, Lynne M. Mofenson, M.D., F.A.A.P. Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1. New England Journal of Medicine. 1999 Dec 16; 341(25):1874-81.

Citation

Ian Marschner, Ph.D., Rebecca Betensky, Ph.D., Victor DeGruttola, Sc.D., Scott M. Hammer, M.D., Daniel R. Kuritzkes, M.D. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Mar 01; 20(3):220-7.

Citation

Heather D. Watts, M.D., Catherine Spino, Sc.D., Larry Zaborski, M.S., David Katzenstein, M.D., Scott M. Hammer, M.D., Constance A. Benson, M.D. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 Apr 15; 20(5):455-62.

Citation

Abhay H. Patki, Scott F. Purvis, Ph.D., Hernan Valdez, John Spritzler, Sc.D., Elizabeth Connick, Daniel R. Kuritzkes, Harold Kessler, Lawrence Fox, Marty St. Clair, Alan Landay, Michael M. Lederman, M.D. HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication. AIDS. 1999 Jul 09; 13(10):1177-85.

Citation

Huldrych F. Gunthard, Andrew J. Leigh-Brown, Richard T. D'Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Joseph K. Wong. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology. 1999 Jun 20; 259(1):154-65.

Citation

Stanley C. Deresinski, M.D., F.A.C.P. Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection. AIDS. 1999 Apr 16; 13(6):633-43.